AstraZeneca delivers good news on Naloxegol

27th Sep 2013 07:31

Pharmaceutical giant AstraZeneca said the European Medicines Agency had accepted the marketing authorisation application for its constipation tablet Naloxegol.The investigational drug is aimed at relieving constipation caused by pain-killing opioid medicines. It was developed using technology from American biopharmaceutical company Nektar Therapeutics. Under the terms of their licensing agreement, the green light from European regulators means AstraZeneca must now make a $25m milestone payment to Nektar.TB

Top Risers

Share	Price	Change
Itm Power (ITM)	132.90	41.61%
PipeHawk (PIP)	3.50	40%
Trafalgar Prop (TRAF)	0.0325	32.65%
Ensilica (ENSI)	64.00	21.9%
Cora Gold (CORA)	11.75	14.63%

Top Fallers

Share	Price	Change
Digital 9 (DGI9)	4.80	-30.23%
Quantum Helium (QHE)	0.032	-20.99%
Workspace (WKP)	330.80	-11.46%
Arc Minerals (ARCM)	0.50	-9.09%
Mothercare (MTC)	1.07	-8.94%

Top By Volume

Share	Price	Volume
Quantum Helium (QHE)	0.032	3,219,946,476
Premier African Minerals (PREM)	0.0195	2,669,394,510
Ethernity Net (ENET)	0.0027	576,662,086
Caledonian Hold (CHP)	0.0042	257,198,228
Trafalgar Prop (TRAF)	0.0325	208,034,322

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.